[go: up one dir, main page]

0% found this document useful (0 votes)
45 views41 pages

Foundation Module Study Guide 2024

Uploaded by

Egg Tor
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOC, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
45 views41 pages

Foundation Module Study Guide 2024

Uploaded by

Egg Tor
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOC, PDF, TXT or read online on Scribd
You are on page 1/ 41

Session 2024-2028

FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

TABLE OF CONTENTS

Content Page number


Foundation Module Team 03
Module Team
Academic Team
PBL Group 04
DCH & Clerkship Groups 05
Programme evaluation Committee 06
Mentoring Groups 07
Assessment guideline for students 08
Attendance guideline 09
Introduction / Rationale 10
Learning Objectives 12-30
Learning Resources 30
Total Teaching Hours 31
Assessment schedule 32

FOUNDATION MODULE 2
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

FOUNDATION MODULE

PLACEMENT IN CURRICULUM: Module 01 in 1st Year

MODULE CODE: FND 101

MODULE DURATION: 09 weeks

PRE-REQUISITE: Prior Knowledge of Intermediate /A-


levels

MODULE TEAM
CHAIRMAN CURRICULUM Prof. Dr. Mahwish Arooj
COMMITTEE
CURRICULUM CO-CHAIR Prof. Dr. Farrukh Iqbal

MODULE DIRECTOR Prof. Dr. Ghazala Irshad

MODULE COORDINATOR Dr. Nadeem Abbas

ACADEMIC TEAM
ANATOMY Dr. Saba Amjad

PHYSIOLOGY Prof. Dr. Samina Malik

BIOCHEMISTRY Dr. Muzamil Liaqat Ali

PATHOLOGY Dr. Lubna Humayun

COMMUNITY MEDICINE Dr. Shamaila Faisal

PHARMACOLOGY Dr. Nada

BEHAVIORAL SCIENCES Miss Naseem. H. Malik

PERL Dr. Khadija Mukhtar

MEDICAL EDUCATION Dr. Azka Ali

FOUNDATION MODULE 3
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

PBL GROUP

Batch # Facilitator Name Venue

Dr. Saba Amjad &


A1 Dissection Hall 1
Dr. Amina

Pathology Museum
A2 Dr. Sadaf Jaffery
:
Dr. Faizan Zafar
B1 Physiology Lab·

B2 Dr. Rida Pharmacology Lab

Dr. Saba Saleem &


C1 Dissection Hall 2
Dr. Usama

Pathology
C2 Dr. Sobia Anwer
Demonstration Room

Physiology
D1 Dr. Maria
Demonstration Room

Community Medicine
D2 Dr. Salman Pasha
Demonstration Room-I

Dr. Saba Iqbal &


E1 Biochemistry Lab
Dr. Muzamil Liaqat Ali

E2 Dr. Sibgha & Dr. lfrah Anatomy Museum

Community Medicine
F1 Dr. Awais
Demonstration Room-II

Biochemistry
F2 Dr. Alina
Demonstration Room

FOUNDATION MODULE 4
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

FOUNDATION MODULE 5
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

DCH & CLERKSHIP GROUPS

Groups Roll #
Batch A 1-25

Batch B 26-50

Batch C 51-75

Batch D 76-100

Batch E 101-125

Batch F 126-150

FOUNDATION MODULE 6
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

FOUNDATION MODULE 7
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

PROGRAM EVALUATION COMMITTEE

# Name of Member

1 Prof. Dr. Mahwish Arooj Chairperson Program Evaluation Committee

2 Prof. Dr. Syed Hasan Shoaib Co-Chairperson Program Evaluation Committee


&
Prof. Dr. Ghazala Irshad 2nd Year Program Evaluation In-charge

3 Dr. Khadija Mukhtar Program Evaluation Coordinator &


st
1 Year Program Evaluation In-charge
4 Dr. Sadia Leghari 3rd Year Program Evaluation In-charge

5 Dr. Khadija Mastoor 4th Year Program Evaluation In-charge

6 Dr. Qurat-ul-Ain Leghari Final Year Program Evaluation In-charge

FOUNDATION MODULE 8
Senior Maria.shakeel@ucm.uol.edu.pk
Demonstrator, 0320-5033603
Physiology
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

MENTORING GROUPS
Batch Designation &
# Name Email & Phone #
# Department
Raana.akhtar@ucm.uol.edu.pk,
1 A-I Dr. Raana Akhtar AP, Pathology 0333-4433827

Zeeshan.malik@ucm.uol.edu.pk,
2 A-II Dr. Zeeshan Malik AP, Cardiology 0331-2000311

rida.shahid@ucm.uol.edu.pk,
Sr. Demonstrator,
3 B-I Dr. Rida Shahid 0324-5214422
Pharmacology
zakia.saleem@ucd.uol.edu.pk,
4 B-II Dr. Zakia Saleem AP, DME 0324-4729099

muhammad.naveed2@ucm.uol.edu.
5 C-I Dr. M. Naveed AP, Pediatrics pk, 0333-4383439

saba.saleem@ucm.uol.edu.pk,
6 C-II Dr. Saba Saleem AP, Anatomy 0321-7542022

ammar.qasim@ucm.uol.edu.pk,
7 D-I Dr. Ammar Qasim Demonstrator, DME 0334-7525268

Hajra.rehanuol@gmail.com,
Sr. Demonstrator,
8 D-II Dr. Hajra Ahmad 0313-5406634
Anatomy
Azka.ali@ucm.uol.edu.pk,
9 E-I Dr. Azqa Ali Demonstrator, DME 0323-9635426

zobiah.hafiz@ucm.uol.edu.pk,
10 E-II Dr. Zobiah Hafiz AP, Physiology 0332-0074392

Nooria.naeem@ucm.uolo.edu.pk,
11 F-I Dr. Nooria Naeem AP, Physiology 0334-4235111

Director Program
Shoaibsumayya@gmail.com,
12 F-II Prof. Dr. Syed Hasan Shoaib Evaluation and Quality
0300-5559640
Assurance, DME
Maria.shakeel@ucm.uol.edu.pk
Dr. Maria Shakeel 0320-5033603
(Senior Demonstrator, Physiology & Mentoring coordinator)

FOUNDATION MODULE 9
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

ASSESSMENT GUIDELINES FOR STUDENTS:


1. The assessment will be held at multiple data points.
2. Each assessment will have a certain weightage in the final score of the students.
3. These assessments will be held as low stake of individual module, CBA the combined assessment of
a number of modules and end of year examination
4. Each assessment will have a theory and OSPE component of equal weightage.
Continuous (Low stake assessment):
 These assessments will be held towards the end of the module when at least 60% of the course has
been completed
 Appearance in all low stake assessments is mandatory to appear in CBA exam
 The Theory will be conducted by individual departments according to the schedule notified in the
time table and will be of 25 marks.
 Combined weightage of these theory assessments will be 10%.
 There will be an integrated OSPE towards the end of the module.
 The OSPE Component will have a combined weightage of 10%
Combined Block Assessment (CBA):
 There will be two or three Combined Block Assessments in each year depending upon the
number of modules and duration of Academic session.
 CBA is the combined assessment of a number of modules
 Students will be given1 week preparatory leave before Combined Block Assessment
 The theory component will comprise of 225 MCQ of 225 marks and will have a weightage of
30%
 The OSPE component will comprise of 33 OSPE stations of 05 marks each and 4 min
duration and 12 OSVE stations of 05 marks and 4 minutes duration
 The OSVE will be conducted by designated departments in respective CBA
Annual Professional Examinations:
 The Annual professional examination will comprise of two to three papers depending upon the
number of CBA in the academic session.
 The professional examination will be held on the same pattern as the CBA
 The theory and OSPE component will have 60% weightage each
 It will be mandatory to pass in each component (theory and practical) of every paper individually in
order to be declared pass in that particular examination.

FOUNDATION MODULE 10
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

ATTENDANCE GUIDELINES
 No student should be eligible for a university examination without having attended 75% of the
lectures, demonstrations, tutorials and practical or clinical work both in- patients and out-patients.
 These guidelines are in accordance with PMDC rules and regulations criteria will be debarred from
the annual professional examination and will automatically be allowed to take the supplementary
examination for that particular year.

• Professional examination End of the year exam


• 60%
• (Theory and OSPE)
• CBA
• Combined Block Assessment of a number of modules
• 30%
• (Theory and OSPE)
• Low stake towards the end of individual module
• 10%
• (Theory and OSPE)

FOUNDATION MODULE 11
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

INTRODUCTION / RATIONALE

Introduction
This module will familiarize the students with basic medical disciplines. It has been selected to impart the
student with basic knowledge about the normal structure, development, organization, functions, transport
and homeostatic control mechanisms of human body. This knowledge will serve as a fabric on which the
student will weave further knowledge about the etiology, pathogenesis and prevention of diseases; the
principles of their therapeutics and management; as well as the toxic effects of different substances.

Module Outcomes: Knowledge, Skills, Attitude


Each student will be able to:
 Knowledge: Acquire the basic scientific knowledge and terminology necessary to understand the
normal structure and function of human body from biochemical to organ system level, as well as
the concepts of diseases in the community and drug dynamics.
 Relate Position and Movements of various Joints with anatomical planes and axes.
 Should be able to differentiate various slides of epithelium and connective tissue.
 Should be able to observe protocols of self-hygiene and respect for prosected human parts and
specimens
 Skill: Analyze and interpret the results of various procedures.
 Attitude: Demonstrate a professional attitude, team building spirit and good communication.

FOUNDATION MODULE 12
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

FOUNDATION MODULE 13
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

MODULE BLUE PRINT


S# TOPIC DISCIPLINE LEARNING OBJECTIVES LEARNIN NO OF ASSES
G HOUR S
STRATEG S MENT
Y TOOL
1. EVOLUTION OF Communit  Explain different eras of Interactiv 01 MCQs
HEALTH CARE y Medicine medicine e Lecture
 Describe different systems of
medicine
2. PRINCIPLES OF Anatomy  Define various developmental Interactiv 01 MCQs
ANATOMY-I periods e Lecture
 Develop the concept map of
structures met in dissection
3. PRINCIPLES OF Anatomy  Define cell cycle Interactiv 01 MCQs
ANATOMY-II  Enlist various stages of cell cycle e Lecture
and factors affecting them
 Define various types of growth
and give their mechanisms
4. USE OF Anatomy  Identify parts of microscope Skill Lab 02 OSPE/
MICROSCOPE  Focus the given slide on MCQs
microscope at different
magnifications
 Explain the underlying principles
of Hematoxylin and Eosin
staining
5. CELL Anatomy  Define animal cell and give main Interactiv 01 MCQs
STRUCTURE - I differentiating points between e Lecture
animal and plant cells
 Enumerate various components
of a typical animal cell
6. CELL Anatomy  Differentiate between Interactiv 01 MCQs
STRUCTURE - II organelles and inclusions. e Lecture
 Relate the staining properties of
various organelles with their
structure
 Relate the various function of
various organelles with their
location in the cell
7. BIOCHEMICAL Biochemist  Describe the structure of cell Interactiv 01 MCQs
COMPOSITION ry membrane e Lecture
OF CELL I  Describe the biochemical
composition of the cell
membrane
 Explain the function of cell
membrane
 Enumerate the types of protein
present in the membrane and
corelate their structure with
functions
 Enlist the major lipids and their
functions
 Explain the fluid mosaic model
of cell with diagram
8. BIOCHEMICAL Biochemist  Describe the biochemical Interactiv 01 MCQs
COMPOSITION ry composition of the cell e Lecture

FOUNDATION MODULE 14
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

S# TOPIC DISCIPLINE LEARNING OBJECTIVES LEARNIN NO OF ASSES


G HOUR S
STRATEG S MENT
Y TOOL
OF CELL II 

 environment
 Describe the structure and
functions of cell organelles
 Enlist the markers of different
cell organelles
 Relate these markers with their
clinical importance
9. ANATOMICAL Anatomy  Describe the anatomical planes Skill Lab 02 MCQs/
POSITION AND with the help of diagrams. OSPE
DIRECTIONAL Coronal
TERMS - I Sagittal
Horizontal
Parasagittal
 Differentiate between planes
and axes
 Mark different movements of
joints with anatomical planes
and axes on cadavers/similated
subjects
10. ANATOMICAL Anatomy  Demonstrate the movements of Skill Lab 02 OSPE
POSITION AND various joints in relation to
DIRECTIONAL planes and their axes.
TERMS – II
11. HOMEOSTASIS Physiology  Define homeostasis Interactiv 01 MCQS
 Compare homeostatic e Lecture
mechanisms of the major
functional systems.
12. INTRODUCTION Biochemist  Underline lab techniques Skill 02 OSPE
TO USE OF ry  General guide lines Lab
LABORATORY  Handing of chemicals
FACILITIES /  Handing of glass ware and
EQUIPMENT equipment
AND SAFETY  Lab regulations
MEASURES  Prevention of Lab hazards
 Identify the following
instruments:
 Glass ware
 Bunsen burner
 Weight Balance
 Water bath
 Describe their principle, working
and uses
13. CONTROL Physiology  Describe the characteristics of Interactiv 01 MCQS
SYSTEM OF THE control systems of the body. e Lecture
BODY  Compare three different types
of feedback mechanisms:
 Negative feedback
 Positive feedback
 Feed forward/Adaptive control
14. BODY FLUIDS-I Biochemist  Describe the concept of pH, pH Interactiv 01 MCQs
ry scale (Acidity and alkalinity), e Lecture
weak acids and their conjugate
FOUNDATION MODULE 15
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

S# TOPIC DISCIPLINE LEARNING OBJECTIVES LEARNIN NO OF ASSES


G HOUR S
STRATEG S MENT
Y TOOL
bases (buffers)
 Describe the importance of
Henderson-Hasselbalch
Equation in defining the
relationship between pH and
the concentrations of conjugate
acid and base (No derivation)
 Define buffers.
 Enumerate the different buffer
systems of the body.
 Describe the role of buffers in
controlling body pH
15. BODY FLUIDS-II Biochemist  Describe the distribution of body Interactiv 01 MCQs
ry fluids in various compartments e Lecture
 Differentiate between
intracellular and extracellular
fluids
 Describe surface tension,
viscosity, and osmosis
 Describe the role of surface
tension in lipid digestion
 Describe the role of viscosity in
blood flow
 Describe the role of osmosis in
edema
16. Body Fluids III Biochemist  Define pK value and Lecture 01 MCQ
(pK values, ry dissociation constant
Dissociation  Explain the titration curve
constant and with examples
titration
curves)
17. Solution Biochemist  Define solute, solvent and Skill Lab 02 OSPE
Preparation ry solutions
 Define types of solutions
including percent, molar, molal
and normal solution
 Define standard solution
 Prepare a solution of normal
saline, 0.9% NaCl with its
calculations

18. INTRODUCTION Pharmacol  Define pharmacology, drug, Interactiv 01 MCQs


TO PHARMA- ogy pharmacodynamics, e lecture
COLOGY-I pharmacokinetics, pro-drug,
placebo, xenobiotics,
pharmacogenomics, toxins,
poisons, teratogen and orphan
drugs
 Discuss the rationale of
prescribing drugs
19. INTRODUCTION Pharmacol • Enlist the different sources Interactiv 01 MCQs
TO PHARMA- ogy of drugs. e Lecture
COLOGY-II • Describe FDA teratogenic
FOUNDATION MODULE 16
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

S# TOPIC DISCIPLINE LEARNING OBJECTIVES LEARNIN NO OF ASSES


G HOUR S
STRATEG S MENT
Y TOOL
risk categories.
• Describe drug’s
nomenclature.
• Define pharmacopoeia.
• Enlist different types of
pharmacopoeias.
• Describe the important
information given in the
pharmacopoeias.
20. INTRODUCTION Pharmacol  Describe the significance of Skill Lab 02 OSPE
TO ogy experimental pharmacology.
EXPERIMENTAL
PHARMACOLO • Demonstrate the SOPs for
GY conduction of experiments in
the laboratory.
• Demonstrate the role of
different laboratory animals
used in experimental
pharmacology.
• Demonstrate the SOPs for
animal handling.
 Demonstrate the proper
techniques for setting of
apparatus involved in
experimental pharmacology.

21. WEIGHTS AND Pharmacol  Discuss the weights and Skill lab 02 MCQ/
MEASURES ,AB ogy measures commonly OSPE
BREVIATIONS used in medical practice
 Enlist the common
abbreviations used while
prescribing the drug
 Demonstrate the
technique of weighing
different chemicals
22. DOSAGE Pharmacol  Calculate the dose of SGD 01 MCQ/
CALCULATIONS ogy drug according to age OSPE
and body weight by using
different formulas
 Calculate the
pharmacokinetic
parameters:
plasma half-life, loading
dose, maintenance dose,
drug clearance and volume
of distribution of a drug.
23. STRUCTURE OF Anatomy  Define cell junctions. Interactiv 01 MCQs
CELL  Classify cell junctions. e Lecture
JUNCTIONS  Compare the structure of
different types of cell junctions.
24. CELL Physiology  Relate the structure of gap and Interactiv 01 MCQs
JUNCTIONS occluding junctions with their e Lecture
FOUNDATION MODULE 17
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

S# TOPIC DISCIPLINE LEARNING OBJECTIVES LEARNIN NO OF ASSES


G HOUR S
STRATEG S MENT
Y TOOL
(OCCLUDING functions
JUNCTIONS
AND GAP
JUNCTION)
25. BIOCHEMISTRY Biochemist  Define carbohydrates Interactiv 01 MCQs
OF CARBO- ry  Classify the carbohydrates. e Lecture
HYDRATES-I  Enlist the functions of
carbohydrates in cell
membrane, energy provision,
supply of nutrition to different
body parts
26. ROUTES OF Pharmacol  Enlist different dosage forms of Skill Lab 01 MCQs/
DRUG ADMIN- ogy drugs OSPE
ISTRATION  Discuss the factors that
influence the route of
administration of a drug
 Discuss the merits & demerits of
the different routes of drug
administration
 Demonstrate the different
routes of drug administration.
27. BIOCHEMISTRY Biochemist Interactiv 01 MCQs
OF CARBO- ry  Define the phenomenon of e Lecture
HYDRATES-II isomerism
 Describe the different types of
isomers of monosaccharides
 Describe their structures
 Describe the clinical importance
of isomers of monosaccharides
 Describe the chemical
properties of monosaccharides
28. BIOCHEMISTRY Biochemist  Describe the role of deoxy Interactiv 01 MCQs
OF CARBO- ry sugars in genetics e Lecture
HYDRATES-III  Describe the structure and
functions of important
disaccharides and
oligosaccharides
 Describe the role of lactose in
infant nutrition
29. COMMUNI- Physiology  Relate the structure of Interactiv 01 MCQs
CATING AND communicating and anchoring e Lecture
ANCHORING cell junctions with their
JUNCTIONS functions.
30. BASIC Physiology  Compare the following Interactiv 01 MCQs
MECHANISMS mechanisms of transport: e Lecture
OF TRANSPORT  Passive transport
–I  Active transport
 Describe simple diffusion
 Compare the following Gated
Channels:
 Voltage gated channels
 Ligand gated channels
 Mechanically gated channels
 Describe facilitated diffusion
FOUNDATION MODULE 18
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

S# TOPIC DISCIPLINE LEARNING OBJECTIVES LEARNIN NO OF ASSES


G HOUR S
STRATEG S MENT
Y TOOL
 Describe the factors affecting
rate of diffusion.
31. BASIC Physiology  Compare these special Interactiv 01 MCQs
MECHANISMS types of passive e Lecture
OF TRANSPORT transports:
- II  Bulk flow
 Filtration
 Osmosis
32. BASIC Physiology  Describe active transport. SGD (TBL) 01 MCQ
MECHANISMS  Identify the diagrammatic This is
OF TRANSPORT representation of different Task
- III transport mechanisms. based
learning
not Team
based
learning

33. AGING Physiology  Discuss the physiological Interactiv 01 MCQs


changes in different body e Lecture
systems due to aging.
34. BIOCHEMISTRY Biochemist  Define polysaccharides Interactiv 01 MCQs
OF CARBO- ry  Describe the structure and e Lecture
HYDRATES IV biomedical importance of the
following homopolysaccahrides:
 Starch in diet
 Glycogen as storage form of
glucose
 Cellulose as a bulk providing
agent in the diet
 Describe the role of inulin in
determining the GFR
35. BIOCHEMISTRY Biochemist  Classify heteropolysaccharides. Lecture 01 MCQ
OF CARBO- ry  Describe the structure of
HYDRATES-V glycosaminoglycan’s and
proteoglycans
 Describe the biomedical
importance of
heteropolysaccharides
36. CARBO- Biochemist  Perform lab tests for qualitative Skill Lab 02 OSPE
HYDRATES ry detection of carbohydrates
QUALITATIVE (Molisch’s test & iodine)
ANALYSIS-I  Describe the principle of these
tests
 Describe the importance of
these tests for the presence and
for the detection of amount of
glucose in given samples
37. CARBO- Biochemist  Perform lab tests for qualitative Skill Lab 02 OSPE
HYDRATES ry detection of carbohydrates
QUALITATIVE (Benedict’s test)
ANALYSIS-II  Describe the principle of this
test
 Describe the importance of this
tests for the quantitative
FOUNDATION MODULE 19
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

S# TOPIC DISCIPLINE LEARNING OBJECTIVES LEARNIN NO OF ASSES


G HOUR S
STRATEG S MENT
Y TOOL
detection of glucose in given
samples
38. PHARMA- Pharmacol  Define absorption of drugs. Interactiv 01 MCQs
COKINETICS ogy  Describe the factors affecting e Lecture
(Drug the absorption of drugs
absorption)  Define bio-availability of a drug
 Define first pass effect
 Discuss clinical significance of first
pass effect
39. PHARMACOKIN Pharmacol  Enlist different pharmacokinetic TBL 02 MCQs
ETICS ogy parameters.
PARAMETERS  Discuss clinical significance of
different pharmacokinetic
parameters.
40. EPITHELIUM-I Anatomy • Classify the body tissues. Interactiv 01 MCQs
Define epithelium e Lecture
Enlist the characteristics of
epithelium
Classify epithelium
Relate the structure and function of
simple epithelium and its
modification with their location

41. EPITHELIUM-II Anatomy Interactiv 01 MCQs


 Compare the structure and e Lecture
function of various stratified
epithelia.
 Apply the knowledge of
epithelial characteristics to
metaplasia, epithelial
regeneration and tumor
development.

42. EPITHELIUM-III Anatomy  Classify glandular epithelium Interactiv 01 MCQs


with examples e Lecture
 Define an acinus, follicle and
endocrine and exocrine glands

43. Epithelium-IV Anatomy  Differentiate between mucous Interactiv 01 MCQs
and serous acini e Lecture
 Define a Demilune
44. EPITHELIUM-I Anatomy  Identify simple epithelium Skill Lab 02 OSPE
 Enlist two points of
identification
 Draw a labeled diagram
45. EPITHELIUM-II Anatomy  Identify simple columnar Skill Lab 02 OSPE
epithelium with modifications
 Enlist two points of
identification
 Draw a labeled diagram
46. EPITHELIUM-III Anatomy  Identify stratified epithelium Skill Lab 02 OSPE
 Enlist two points of

FOUNDATION MODULE 20
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

S# TOPIC DISCIPLINE LEARNING OBJECTIVES LEARNIN NO OF ASSES


G HOUR S
STRATEG S MENT
Y TOOL
identification
 Draw a labeled diagram
47. EPITHELIUM-IV Anatomy  Identify glandular epithelium Skill Lab 02 OSPE
 Enlist two points of
identification
 Draw a labeled diagram
48. BIOCHEMISTRY Biochemist  Define lipids Interactiv 01 MCQs
OF LIPIDS-I ry  Classify lipids e Lecture
 Describe the biomedical
importance of lipids.
 Define Fatty acids
 Classify fatty acids
 Describe the role of
prostaglandins
 Describe the role of leukotrienes
 Describe the role of
thromboxanes in platelet
aggregation

49. BIOCHEMISTRY Biochemist  Describe the structure of Interactiv 01 MCQs


OF LIPIDS-II ry phospholipids, glycolipids and e Lecture
sphingolipids
 Describe the role of glycolipids
and phospholipids in cell
membrane
50. BIOCHEMISTRY Biochemist  Describe the role of Interactiv 01 MCQs
OF LIPIDS-III ry phosphatidylcholine in nerve e Lecture
transmission
 Describe the role of
sphingolipids in nervous system
 Describe the role of gangliosides
in cholera
 Describe the importance of
cholesterol.
51. LIPIDS Biochemist  Perform the Fat qualitative Skill Lab 02 OSPE
QUALITATIVE ry analysis (grease spot, solubility,
ANALYSIS saponification and
emulsification tests)
 Describe the principles of fat
qualitative analysis

52. GENERAL Anatomy  Describe the general features of Interactiv 01 MCQs


ANATOMY OF bone e Lecture
BONES - I  Describe the blood supply of
long bones
53. GENERAL Anatomy  Classify bones according to SGD 01 MCQs
ANATOMY OF  Development
BONES - II  Gross appearance
 Histology
54. GENERAL Anatomy  Identify the bones provided. Skill Lab 01 OSPE
ANATOMY OF  Categorize them according to
BONES - III their gross appearance
 Perform side determination of
bone provided.
FOUNDATION MODULE 21
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

S# TOPIC DISCIPLINE LEARNING OBJECTIVES LEARNIN NO OF ASSES


G HOUR S
STRATEG S MENT
Y TOOL
55. GENERAL Anatomy  Classify muscles with examples Interactiv 01 MCQs
ANATOMY OF according to e Lecture
MUSCLE  Shape
 Histology
 Architecture
56. GENERAL Anatomy  Describe the general features of SGD 01 MCQs
ANATOMY OF skeletal muscle
MUSCLE - I  Describe the blood supply and
nerve supply of muscle
 Describe the anatomical
structures of the muscle tissue
(atrophy) involved in atrophy of
a limb
57. GENERAL Anatomy  Identify the muscles based on SGD 01 MCQs
ANATOMY OF the reaction
MUSCLE - II  Demonstrate the actions of
Prime movers, Agonists,
Antagonists Fixators, Synergists

58. DRUG Pharmacol  Define drug distribution Interactiv 01 MCQs
DISTRIBUTION ogy  Describe factors affecting drug e Lecture
(Pharmacokine distribution
tic)  Define volume of distribution
(Vd)
 Describe the clinical significance
of Vd
 Define loading dose &
maintenance dose
 Discuss the clinical significance
of giving drugs through loading
dose & maintenance dose
 Describe plasma protein binding
of the drugs with its clinical
significance
59. MITOSIS AND Anatomy  Describe the process of mitosis Interactiv 01 MCQs
MEIOSIS - I and meiosis e Lecture
 Differentiate between mitosis
and meiosis
60. MITOSIS AND Anatomy  Classify the structural and Interactiv 01 MCQs
MEIOSIS - II numerical abnormalities of e Lecture
chromosomes
 Apply the knowledge of
chromosomal abnormalities to
understanding of clinical
conditions
61. BIOCHEMISTRY Biochemist  Define amino acids Interactiv 01 MCQs
OF PROTEINS & ry  Classify amino acids e Lecture
AMINO ACIDS-I  Describe their structure,
properties and biochemical
functions
62. BIOCHEMISTRY Biochemist  Define proteins Interactiv 01 MCQs
OF PROTEINS & ry  Classify proteins on the basis of: e Lecture
AMINO ACIDS-II  Physicochemical properties
 Function
FOUNDATION MODULE 22
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

S# TOPIC DISCIPLINE LEARNING OBJECTIVES LEARNIN NO OF ASSES


G HOUR S
STRATEG S MENT
Y TOOL
 Nutritional requirement
 Structure
 Enlist the biochemical functions
of proteins
63. BIOCHEMISTRY Biochemist  Describe the higher orders of Interactiv 01 MCQs
OF PROTEINS & ry structure of proteins (Primary, e Lecture
AMINO ACIDS- secondary, tertiary &
III quaternary)
 Describe the mechanism by
which mutations in the order of
structure of protein lead to
different diseases like
Alzheimer’s disease,
Amyloidosis, Creutzfeldt- Jacob’s
disease and hemoglobinopathies
64. BIOCHEMISTRY Biochemist  Enlist plasma proteins with their Biochemi 01 MCQs
OF PROTEINS & ry normal levels in blood stry
AMINO ACIDS-  Explain the synthesis and
IV biochemical properties of
plasma proteins
 Describe the functions of plasma
proteins
 Explain the biomedical
importance of plasma proteins
65. PROTEIN Biochemist  Perform protein qualitative Skill Lab 02 OSPE
QUALITATIVE ry analysis (Biuret’s, Isoelectric
ANALYSIS Point, Heat Coagulation)
 Describe the principles of tests
on protein qualitative analysis
66. Separation of Biochemist  Detect the proteins in the given Skill Lab 02 OSPE
proteins ry solution by salt saturation test.
67. CONNECTIVE Anatomy  Explain the components of Interactiv 01 MCQs
TISSUES - I connective tissue e Lecture
 Classify connective tissue with
examples
 Justify the location of each type
of connective tissue on the basis
of its structure
68. CONNECTIVE Anatomy  Explain role of fibroblasts in Interactiv 01 MCQs
TISSUES - II wound contraction e Lecture
 Describe the role of collagen in
keloid and hypertrophic scar
69. CONNECTIVE Anatomy  Identify different types of Skill lab 02 OSPE
TISSUES connective tissue under
microscope
 Enlist two points of
identification for each slide
 Draw labelled diagram of each
type of connective tissue on
sketch copy
70. Gametogenesis Anatomy  Define Gametogenesis Interactiv 01 MCQs
-I  Describe the events of e Lecture
spermatogenesis
 Differentiate between
FOUNDATION MODULE 23
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

S# TOPIC DISCIPLINE LEARNING OBJECTIVES LEARNIN NO OF ASSES


G HOUR S
STRATEG S MENT
Y TOOL
spermiogenesis and
spermatogenesis
 Describe the relationship of sub-
fertility with production of
abnormal sperms
 Define terms
 Azoospermia
 Oligospermia
71. GAMETOGENES Anatomy Interactiv 01 MCQs
IS-II  Define oogenesis e Lecture
 Describe the pre-natal and post-
natal maturation of oocyte
 Differentiate between
spermatogenesis and oogenesis
72. Pharmacokine Pharmacol  Define biotransformation Interactiv 01 MCQs
tic (BIO-TRANS- ogy  Describe the aims and outcomes e Lecture
FORMATION - I) of Biotransformation
 Enlist phase I and phase II
biotransformation reactions
 Describe the clinical significance
of biotransformation
 Enlist factors affecting
biotransformation of a drug
73. Pharmacokineti Pharmacol  Define enzyme induction & Interactiv 01 MCQs
c (BIO-TRANS- ogy enzyme inhibition e Lecture
FORMATION -  Describe the clinical significance
II) of enzyme induction and
enzyme inhibition
 Enlist enzyme inducers and
enzyme inhibitors
74. OVULATION Anatomy  Describe the relation between Interactiv 01 MCQs
AND hypothalamo-hypophseal , e lecture
TRANSPORT OF ovarian and uterine cycles
OVUM  Describe the structure and
formation of corpus luteum and
corpus albicans
 Describe the mechanism of
ovulation and transport through
fallopian tubes
 Describe the middle pain
(mittelshimerz) associated with
ovulation
75. FERTILIZATION Anatomy Interactiv 01 MCQS
 Explain the process of e Lecture
capacitation
 Describe the passage of
spermatozoa through barriers
surrounding the oocyte.
 Discuss the outcomes of
fertilization
 Define the terms IVF & assisted
IVF
76. BIOCHEMISTRY Biochemist  Describe the chemistry, Interactiv 01 MCQs
OF ry structure and the biochemical e Lecture
FOUNDATION MODULE 24
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

S# TOPIC DISCIPLINE LEARNING OBJECTIVES LEARNIN NO OF ASSES


G HOUR S
STRATEG S MENT
Y TOOL
NUCLEOTIDES role of nucleosides and
& NUCLEIC nucleotides
ACIDS-I  Describe the role of nucleotides
in energy provision,
phosphorylation, DNA / RNA
synthesis and protein synthesis
 List the disorders associated
with nucleotides
77. BIOCHEMISTRY Biochemist  Define nucleic acid Interactiv 01 MCQs
OF ry  Enlist nucleic acids and their e Lecture
NUCLEOTIDES types,
& NUCLEIC  Describe the structure of nucleic
ACIDS-II acid
 List the differences between
different types of nucleic acids
 Discuss the functions of
different types of nucleic acids

78. INTRODUCTION Pathology  Define the following terms: Interactiv 01 MCQs


TO PATHOLOGY  Etiology e Lecture
AND CELL  Pathogenesis
INJURY  Morphology
 Describe causes of cell injury
with clinical relevance
79. CELLULAR Pathology  Discuss cellular responses to SGD 01 MCQs
RESPONSES TO injury for:
INJURY  Reversible injury
 Adaptation
 Irreversible injury
 Cell death
 Describe the morphological
changes in cell injury
culminating in necrosis and
apoptosis.
80. MECHANISM Pathology  Describe the mechanism of cell Interactiv 01 MCQs
AND EFFECTS injury e Lecture
OF CELL  Describe the biochemical effects
INJURY-I of ischemic cell injury
 Describe the functional effects
of ischemic cell injury
81. MECHANISM Pathology  Describe the mechanism of cell Interactiv 01 MCQs
AND EFFECTS injury e Lecture
OF CELL  Describe the biochemical effects
INJURY-II of ischemic cell injury
 Describe the functional effects
of ischemic cell injury
82. INTRA- Pathology  Describe the following types of Interactiv 01 MCQs
CELLULAR intracellular accumulations with e lecture
ACCUMULA- clinical examples:
TIONS  Lipids/ fats
 Protein
 Glycogen
 Pigments
 Explain mechanism of
FOUNDATION MODULE 25
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

S# TOPIC DISCIPLINE LEARNING OBJECTIVES LEARNIN NO OF ASSES


G HOUR S
STRATEG S MENT
Y TOOL
intracellular accumulations
 Enlist causes of fatty change
 Describe the pathogenesis of
fatty liver
83. PIGMENTS Pathology  Classify pigments Interactiv 01 MCQs
 Explain the mechanism of e lecture
pigment Production and
deposition in various clinical
settings
 Describe the morphological
features (gross / microscopic)
with deposition of following
pigments:
 Lipofuscin
 Melanin
 Hemosiderin
 Bilirubin
 Anthracosis
84. FREE Pathology  Define ROS/free radicals Interactiv 01 MCQs
RADICALS/  Enlist oxygen derived free e lecture
REACTIVE radicals
OXYGEN  Describe the mechanism of
SPECIES (ROS). generation of free radicals
OXIDATIVE  Describe mechanism of removal
STRESS of free radicals(antioxidants)
 Describe the pathological effects
of free radicals
85. FIRST WEEK OF Anatomy  Describe the mechanism of Interactiv 01 MCQs/
HUMAN implantation. e Lecture OSPE
DEVELOPMENT  Define ectopic pregnancy
 Enlist its different sites of
occurrence.
 Define cleavage, morula and
blastocyst
 Relate the formation of inner
and outer cell mass with
development of embryo.
Identify different stages of
development on models and
diagrams

86. METHODS TO Biochemist  Identify the methods to Skill Lab 02 OSPE


STUDY CELL ry study the cell biochemistry
BIOCHEMISTRY-  Describe the Principle and
I procedures of :
 Salt fractionation
 Ultra-centrifugation
 Chromatography

87. METHODS TO Biochemist  Identify the centrifuge machine Skill Lab 02 OSPE
STUDY CELL ry and its parts
BIOCHEMISTRY-  Demonstration of Centrifugation
II of the given sample
 Describe the principle, working
FOUNDATION MODULE 26
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

S# TOPIC DISCIPLINE LEARNING OBJECTIVES LEARNIN NO OF ASSES


G HOUR S
STRATEG S MENT
Y TOOL
and its uses
88. Pharmacokineti Pharmacol  Define clearance Interactiv 01 MCQs
c (DRUG ogy  Enlist factors affecting total e Lecture
CLEARANCE, clearance
HALF-LIFE AND  Define half-life
ELIMINATION)  Describe the clinical significance
of half-life of drug
 Define steady state
concentration
 Discuss the relationship
between half-life and steady
state concentration
 Describe first and zero order
elimination with examples
89. IRREVERSIBLE Pathology  Define necrosis Interactiv 01 MCQs
INJURY -  Enlist patterns/types with e Lecture
NECROSIS clinical examples
 Describe morphological changes
(gross and microscopic) in
necrosis
90. IRREVERSIBLE Pathology  Define necrosis Interactiv 01 MCQs
INJURY –  Enlist patterns/types with e Lecture
NECROSIS-II clinical examples
 Describe morphological changes
(gross and microscopic) in
necrosis
91. SECOND WEEK Anatomy  Describe the sequential phases Interactiv 01 MCQs/
OF HUMAN of human development during e Lecture OSPE
DEVELOPMENT second week
 Explain why the second week is
known as week of two’s
 Explain the formation of:
Bilaminar Germ disc
Syncytiotrophoblast and
cytotrophoblast
Primary and secondary villi
Amniotic cavity and yolk sac
Identify different stages of
development on models and
diagrams
92. Pharmacokineti Pharmacol  Define excretion Interactiv 01 MCQs
cs (DRUG ogy  Enlist the ways of termination of e Lecture
EXCRETION) action of drugs
 Enlist different routes of drug
excretion
 Describe excretion processes
through kidneys with their
clinical significance
93. DEVELOPMENT Anatomy  Explain the establishment of Interactiv 01 MCQs/
OF UTERO- uteroplacental circulation e Lecture OSPE
PLACENTAL  Describe the mechanism of
CIRCULATION transformation of connecting
AND CHORION stalk into umbilical cord
 Explain the formation of
FOUNDATION MODULE 27
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

S# TOPIC DISCIPLINE LEARNING OBJECTIVES LEARNIN NO OF ASSES


G HOUR S
STRATEG S MENT
Y TOOL
chorion, secondary yolk sac &
chorionic plate
 Explain the clinical relevance of
production of βHCG by the
syncytiotrophoblast and
pregnancy test
 Identify components of fetal and
maternal parts of placenta on
models and diagrams
94. SPECTRO- Biochemist  Identify pipettes, Skill Lab 02 OSPE
PHOTOMETRY ry spectrophotometer and their
AND PIPETTING parts
 Demonstrate the technique of
pipetting
 Describe principle, working,
uses, and limitations of
spectrophotometer
 Perform spectrophotometry
95. ENZYMES-I Biochemist  Classify enzymes Interactiv 01 MCQs
ry  Discus the application of enzyme e Lecture
of different classes in clinical
diagnosis of liver, prostate, bone
and pancreatic diseases
96. APOPTOSIS Pathology  Define apoptosis Interactiv 01 MCQs
 Enlist clinical examples of e Lecture
apoptosis in physiological
conditions
 Enlist clinical examples of
apoptosis in pathological
conditions
 Describe mechanism of
apoptosis
 Tabulate differences between
necrosis and apoptosis
97. APOPTOSIS-II Pathology  Define apoptosis Interactiv 01 MCQs
 Enlist clinical examples of e Lecture
apoptosis in physiological
conditions
 Enlist clinical examples of
apoptosis in pathological
conditions
 Describe mechanism of
apoptosis
 Tabulate differences between
necrosis and apoptosis
98. THIRD WEEK OF Anatomy  Describe the sequential phases Interactiv 01 MCQs
HUMAN of human development during e Lecture
DEVELOPMENT- 3rd week
I  Describe the process of
gastrulation
 Enumerate the derivatives of
ectoderm, mesoderm and
endoderm
99. THIRD WEEK OF Anatomy  Describe the formation of Interactiv 01 MCQs/
FOUNDATION MODULE 28
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

S# TOPIC DISCIPLINE LEARNING OBJECTIVES LEARNIN NO OF ASSES


G HOUR S
STRATEG S MENT
Y TOOL
HUMAN notochord e Lecture OSPE
DEVELOPMENT-  Relate the formation of paraxial,
II lateral plate and intermediate
mesoderm with derivatives
 Describe the involvement of
germ disc layers in teratogenesis
associated with gastrulation like
Situs inversus and caudal
dysgenesis
 Identify features of
development during 3rd Week on
models/diagrmas
100. 4TH TO 8TH Anatomy  Describe the mechanism of Interactiv 01 MCQs
WEEK OF folding of embryo e Lecture
HUMAN  Describe the formation of
DEVELOPMENT- primary and secondary villus
I  Describe the formation of
somites
 Describe the mechanism of
Estimation of the age of embryo
at this stage of development
101. 4TH TO 8TH Anatomy  Describe the process of Interactiv 01 MCQs
WEEK OF neurulation e Lecture
HUMAN  Describe the process of
DEVELOPMENT- separation of neural crest cells
II from neural tube
 Enumerate the derivatives of
neural crest cells
 Relate malformations of CNS
with non-closure of neural tube
102. NECROSIS - Pathology  Identify different types of SGA 01 OSPE
IMAGE SESSION necrosis on image
 Interpret the clinical scenario
with given image
103. FETAL PERIOD Anatomy  Describe the external Interactiv 01 MCQs
appearance of fetus during third e Lecture
to ninth month
 Explain terms like crown rump
length & CHL

 Determine the time of birth


from LNMP
 Enlist methods of the Estimation
of the fetal age at various stages
 Explain the clinical relevance of
(IUGR)variation in fetal length
and weight, with chromosomal
abnormalities, teratogens and
congenital infections
104. TWIN BIRTHS Anatomy  Define monozygotic & dizygotic Interactiv 01 MCQs
twins e Lecture
 Explain the arrangement of fetal
membranes in mono and

FOUNDATION MODULE 29
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

S# TOPIC DISCIPLINE LEARNING OBJECTIVES LEARNIN NO OF ASSES


G HOUR S
STRATEG S MENT
Y TOOL
dizygotic twins.
 Explain terms like vanishing
twins and twin transfusion
syndrome
 Explain the role of partial
splitting of primitive node and
streak in development of
congenital anomalies like
 Craniopagus
 Pyopagus
 Thoracopagus
 Describe the development of
oligo and polyhydramnios with
special reference to formation &
swallowing of amniotic fluid by
the fetus
105. INTRODUCTION Pharmacol  Define pharmacodynamics, Interactiv 01 MCQs
TO ogy agonist, antagonist, partial e Lecture
PHARMACODY agonist, inverse agonist,
NAMICS AND receptors and spare receptors
DRUG  Describe the general
RECEPTOR mechanisms by which drugs act
INTERACTIONS  Describe drug receptor
interactions
 Discuss the concept of down
regulation and up-regulation of
receptor with examples
106. ENZYMES-II Biochemist  Define coenzymes, cofactors Interactiv 01 MCQs
ry and isoenzymes e Lecture
 Describe the relationship
between vitamin deficiency and
activity of coenzymes
 Describe the relationship
between deficiency of minerals
and enzymatic reactions
 Correlate the importance of
isozymes e.g. creatine kinase
and lactate dehydrogenase in
cardiac diseases
107. ENZYMES-III Biochemist  Describe the factors effecting Interactiv 01 MCQs
ry enzyme activities e Lecture
 Correlate the importance of
various factors and action of
enzymes
108. PLACENTAL Anatomy • Describe the composition of Interactiv 01 MCQs
DEVELOPMENT- fetal and maternal portions of e Lecture
I placenta
• Differentiate between
decidua basilis, parietalis and
capsularis
• Explain molar pregnancy and
choriocarcinoma.

109. ENZYMES-IV Biochemist  Describe the mechanism of Interactiv 01 MCQs


FOUNDATION MODULE 30
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

S# TOPIC DISCIPLINE LEARNING OBJECTIVES LEARNIN NO OF ASSES


G HOUR S
STRATEG S MENT
Y TOOL
ry catalysis by giving emphasis on e Lecture
following:
 Energy of activation
 Transition state
 Lock and key model
 Induce fit model
 acid-base strain catalysis,
 covalent catalysis,
 Calcium / Calmodulin
catalysis
110. PLACENTAL Anatomy  Describe the features of full- Interactiv 01 MCQs
DEVELOPMENT- term placenta e Lecture
II  Describe the significance of
placental barrier
 Describe hemolytic disease of
new born in relation to placental
barrier
 Describe the malformations of
placental development
111. DRUG Pharmacol  Define drug antagonism Interactiv 01 MCQs
ANTAGONISM ogy  Describe different types of drug e Lecture
antagonism with examples
112. DRUG Pharmacol  Enlist the different types of drug SGD 01 MCQs/
ANTAGONISM ogy antagonism OSPE
 Describe the clinical significance
of drug antagonism
113. ENZYMES-V Biochemist  Describe the Michaelis-Menten Interactiv 01 MCQs
ry equation and Lineweaver-burke e Lecture
plot
 Describe their application in
enzyme kinetics (no derivation
of equations)
 Define inhibitors
 Classify enzyme inhibitors
 Describe the biomedical
importance of different
inhibitors as drugs e.g. statins,
ACE inhibitors, ethanol
 Describe the biomedical
importance of different
inhibitors such as suicide
inhibitors
114. VITAMINS-I Biochemist  Define vitamins Interactiv 01 MCQs
ry  Classify vitamins e Lecture
 Explain the importance of
water-soluble vitamins (Vitamin
C) & diseases related to it.

115. VITAMINS-II Biochemist  Explain the importance of Interactiv 01 MCQs


ry water-soluble vitamins (Vitamin e Lecture
B Complex) & diseases related
to them
FOUNDATION MODULE 31
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

S# TOPIC DISCIPLINE LEARNING OBJECTIVES LEARNIN NO OF ASSES


G HOUR S
STRATEG S MENT
Y TOOL
116. VITAMINS-III Biochemist  Explain the importance of lipid- Interactiv 01 MCQs
ry soluble vitamins (Vitamin A and e Lecture
D) & diseases related to them
117. VITAMINS-IV Biochemist  Explain the importance of lipid- Interactiv 01 MCQs
ry soluble vitamins (Vitamin E and e Lecture
K) & diseases related to them
118. DOSE Pharmacol  Define efficacy, potency, Interactiv 01 MCQs
RESPONSE ogy therapeutic index, therapeutic e Lecture
CURVES window, tolerance and
tachyphylaxis
 Enlist at least 2 drugs exhibiting
tolerance and tachyphylaxis
 Describe graded-dose response
curves with their clinical
significance
 Describe quantal-dose response
curves with their clinical
significance
119. DRUG Pharmacol  Define Drug interactions. Interactiv 01 MCQs
INTERACTIONS ogy  Describe the type of drug e Lecture
interactions with examples.
 Discuss the clinical significance
of drug interactions.
120. ADVERSE DRUG Pharmacol  Define adverse drug reactions. Interactiv 01 MCQs
REACTIONS ogy  Classify adverse drug reactions. e Lecture
 Enlist the causes of adverse drug
reactions.
 Describe the clinical significance
of adverse drug reactions.
121. FACTORS Pharmacol  Define drug interactions, Interactiv 01 MCQs
AFFECTING ogy synergism, summation and e Lecture
DOSE AND potentiation
ACTION OF A  Enlist different types of drug
DRUG interactions
 Discuss pharmacodynamics drug
interactions with their clinical
importance
 Discuss pharmacokinetic drug
interactions with their clinical
importance
122. MINERAL & Biochemist  Classify minerals Interactiv 01 MCQs
TRACE ry  Discus the biochemical role of e Lecture
ELEMENTS-I macro minerals (Ca, P, Na)

123. MINERAL & Biochemist  Discus the biochemical role of Interactiv 01 MCQs
TRACE ry macro minerals (Mg, K, Cl, S) e Lecture
ELEMENTS-II
124. MINERAL & Biochemist  Discuss the biochemical role of Interactiv 01 MCQs
TRACE ry micro minerals (Zn, Mg, Se, Cu) e lecture
ELEMENTS-III  Describe the anti-oxidant role of
selenium
 Describe the biochemical basis
of Wilson’s disease, Menke’s
disease.
FOUNDATION MODULE 32
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

S# TOPIC DISCIPLINE LEARNING OBJECTIVES LEARNIN NO OF ASSES


G HOUR S
STRATEG S MENT
Y TOOL
125. MINERAL & Biochemist  Discuss the biochemical role of Interactiv 01 MCQs
TRACE ry micro minerals (I, Cr, Cd, Mn, F) e Lecture
ELEMENTS-IV
126. Introduction to Behavioral  Define the term behavioral Interactiv 01 MCQs
Behavioral sciences sciences. e Lecture
sciences-I  Describe the link between
health and behavioral sciences
 Enlist disciplines of behavioral
sciences
 Describe Biopsychosocial model
of health and disease
 Describe the concept of holistic
medicine
127. Introduction to Behavioral Define Non pharmacological Interactiv 01 MCQs
Behavioral Sciences interventions (NPIs) e Lecture
sciences-II Enlist the types of NPIs
Explain the use of non-
pharmacological interventions
(NPIs) in clinical practice.
128. LIFE SPAN Behavioral  Define developmental Interactiv 01 MCQs
DEVELOPMENT Sciences psychology e Lecture
– SOCIAL-  Enlist the stages of life span
EMOTIONAL development
DEVELOPMENT-  Explain the concept of social-
I emotional development
 Describe types of attachment
129. Life span Behavioral  Outline the evidence for Interactiv 01 MCQs
development sceinces perceptual preferences in the e lecture
perception and newborn
communication  Explain the concept of neonate
in the neonate- communication
II  List the various styles of child
rearing and discuss the effects of
each on children
130. Theories of Behavioral • Describe Freud’s psycho- Interactiv 01 MCQs
SOCIAL- Sciences sexual theory of human e Lecture
EMOTIONAL development
DEVELOPMENT-  Describe the clinical
I relevance of pshyco-
analytical theory
131. Theories of Behavioral  Describe the stages of Interactiv 01 MCQs
Social sciences Erikson’s theory of e Lecture
Emotional psychosocial development
development-II  Describe the clinical
relevance of social
emotional development
theories
132. Theories of Behavioral  Describe the concept of Interactiv 01 MCQs
COGNITIVE Sciences cognitive and moral e Lecture
AND MORAL development
DEVELOPMENT-  Describe the principles and the
I stages of Piaget’s theory of
cognitive development

FOUNDATION MODULE 33
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

S# TOPIC DISCIPLINE LEARNING OBJECTIVES LEARNIN NO OF ASSES


G HOUR S
STRATEG S MENT
Y TOOL
133. Theories of Behavioral  Describe Kohlberg’s theory Interactiv 01 MCQs
COGNITIVE Sciences e Lecture
AND MORAL of moral development
DEVELOPMENT-
II  Describe the clinical
relevance of cognitive and
moral development theories

134. INTRODUCTION Anatomy  Define nervous tissue Interactiv 01 MCQs


TO CNS AND  Enumerate components of e Lecture
FORMATION OF central and peripheral nervous
TYPICAL SPINAL system
NERVE  Identify parts of a neuron
 Differentiate between Gray and
White matter
 Describe formation of a typical
spinal nerve
 Identify parts of CNS on models
and specimen
135. INTRODUCTION Anatomy  Define vascular system Interactiv 01 MCQs
TO  Enumerate divisions of e Lecture
CIRCULATORY circulatory system
SYSTEM  Classify blood vessels
 Classify various types of
circulation
 Define and classify anastomosis
 Discuss significance of
anastomosis
136. THE SCIENCE PERL  Define professionalism Interactiv 01 MCQs
AND THE  Define ethics e Lecture
RELIGION  Understand commonalities and
differences between science and
religion about creation of universe.
 Understand commonalities and
differences between science and
religion in theory of evolution.
 Understand Quranic teaching about
creation of Earth and life on it.
 Understand Quranic teaching about
creation of man.
 Understand obligation of being Muslim
 Understand concept of ubodiah.
 Understand characters required for
ubodiah
137. MEDICAL PERL  Define medical ethics Interactiv 01 MCQs
ETHICS  Discuss the history of medical ethics e Lecture
 Describe international code of medical
ethics
 Describe code of medical ethics in
Pakistan
 Enlist ethical duties of physician
according to international code of
ethics

FOUNDATION MODULE 34
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

S# TOPIC DISCIPLINE LEARNING OBJECTIVES LEARNIN NO OF ASSES


G HOUR S
STRATEG S MENT
Y TOOL
138. RESEARCH PERL  Discuss the ethics of Research in Interactiv 01 MCQs
Islam e Lecture
 Discuss the ethics of use of animals In
Research
 Discuss the ethics of Research on
Humans
139. BIOSTATISTICS PERL  Define biostatistics Interactiv 01 MCQs
DATA  Describe data and classify different e lecture
types of data
 Describe the different methods of
presentation of statistical data
13 MEASURES OF PERL Describe the measures of central tendency Interactiv 01 MCQs
9. CENTRAL  Averages e lecture
TENDENCY  Mean
 Modes
14 STANDARD PERL Describe the measures of dispersion Interactiv 01 MCQs
0 DEVIATION  Range e Lecture
 Mean deviation
 Standard deviation

LEARNING RESOURCES
Discipline Reference Book(s)
ANATOMY  Clinical Anatomy by Regions Richard S.Snell
 Medical Histology by Laiq Hussain
 General Anatomy by Laiq Hussain
 Langman Medical Embryology
 Developing human by Keith More
PHYSIOLOGY  Guyton Text Book of Medical Physiology
BIOCHEMISTRY  Chatterjee Biochemistry 8th Edition, Lippincott’s Biochemistry 8th edition,
Mushtaq’s Biochemistry Volume I and II 8th edition
PATHOLOGY  Pathologic Basis Of Disease Robbins & Cotran 8th edition
PHARMACOLOGY  Basic and Clinical Pharmacology by Betram G. Katzung 14th Edition
COMMUNITY  Park’s Text book of Preventive and Social Medicine 25th Edition
MEDICINE
BEHAVIORAL  Integrating Behavioral sciences in medicine by Dr. Asma Humayyon
SCIENCES
 Behavioral sciences in medicine by Barbara Fedem 2nd edition
 Integrating behavioral sciences by Moaadtt Rana 1st and 2nd edition

FOUNDATION MODULE 35
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

MODULE HOURS
TBL SKILL FORMATIVE LOW STAKES INTEGRATED
SUBJECT LECTURE SGDS LAB ASSESSMENT ASSESSMENT OSPE

ANATOMY 36 03 18 04 01

PHYSIOLOGY 09 01 01 01

BIOCHEMISTRY 36 00 24 02 01

PHARMACOLOGY 15 02 02 04 01 01 -

PATHOLOGY 11 01 02 01 01 -

COMMUNITY - - - - -
MEDICINE 01

PERL 06 - - - -

LIFE & LIVING 09 - - - - -

BEHAVIORAL - - - - -
SCIENCES 08

FOUNDATION MODULE 36
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

DCH 00 - 24 - -

24 (Whole - - - -
DSL Class)

MENTORING 02 - - - - -

TOTAL

ASSESSMENT SCHEDULE

Tim Resource
Day Subject Activity Venue
e Person
Thursday, Formative
12:30- Lecture Prof. Dr. IT LAB
March 5, Assessment
13:19 Physiology Samina Malik Basement
2024 Physiology
Friday, Low stake
12:30- Lecture Prof. Dr. IT LAB
March 8, Assessment
13:19 Physiology Samina Malik Basement
2024 Physiology
Tuesday, Formative Lecture
12:30- IT LAB
March 12, Assessment Pharmacolog Dr.Ayela
13:19 Basement
2024 Pharmacology y
Wednesday, Formative
12:30- Lecture Dr. Nadeem IT LAB
March 13, Assessment
13:19 Biochemistry Abbas Basement
2024 Biochemistry - I
Tuesday, Formative
12:30- Lecture Dr. Nadeem IT LAB
March 26, Assessment
13:19 Biochemistry Abbas Basement
2024 Biochemistry - II
Wednesday, Formative
12:30- Lecture IT LAB
March 27, Assessment Anatomy Dr. Saba
13:19 Anatomy Basement
2024 -I
Monday,
10:00- Formative Batch Skill Lab Histology
April 1, Dr.Hajra
10:49 Assessment Histology A Histology Lab
2024
Monday,
10:50- Formative Batch Skill Lab Histology
April 1, Dr.Hajra
11:39 Assessment Histology A Histology Lab
2024
Monday, 10:00- Formative Batch Skill Lab Histology
Dr.Hajra
April 1, 10:49 Assessment Histology B Histology Demo room

FOUNDATION MODULE 37
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

2024
Monday,
10:50- Formative Batch Skill Lab Histology
April 1, Dr.Hajra
11:39 Assessment Histology B Histology Demo room
2024
Tuesday,
08:00- Formative Batch Skill Lab Histology
April 2, Dr.Hajra
08:49 Assessment Histology C Histology Lab
2024
Tuesday,
08:50 Formative Batch Skill Lab Histology
April 2, Dr.Hajra
-09:39 Assessment Histology C Histology Lab
2024
Tuesday,
08:00- Formative Batch Skill Lab Histology
April 2, Dr.Hajra
08:49 Assessment Histology D Histology Demo room
2024
Tuesday,
08:50 Formative Batch Skill Lab Histology
April 2, Dr.Hajra
-09:39 Assessment Histology D Histology Demo room
2024
Wednesday,
08:00- Formative Batch Skill Lab Histology
April 3, Dr.Hajra
08:49 Assessment Histology E Histology Lab
2024
Wednesday,
08:50 Formative Batch Skill Lab Histology
April 3, Dr.Hajra
-09:39 Assessment Histology E Histology Lab
2024
Wednesday,
08:00- Formative Batch Skill Lab Histology
April 3, Dr.Hajra
08:49 Assessment Histology F Histology Demo room
2024
Wednesday,
08:50 Formative Batch Skill Lab Histology
April 3, Dr.Hajra
-09:39 Assessment Histology F Histology Demo room
2024
Wednesday, Formative
12:30- Lecture IT LAB
April 3, Assessment Anatomy Dr.Saba
13:19 Anatomy Basement
2024 - II
Tuesday, Low Stake
12:30- Pharmacolog IT LAB
April 9, Assessment Dr.Shumaila
13:19 y Basement
2024 Pharmacology
Monday, Low stake
12:30- Lecture Dr.Shizra IT LAB
April 15, Assessment
13:19 Pathology Kaleemi Basement
2024 Pathology
Wednesday, Low stake
12:30- Lecture Dr. Nadeem IT LAB
April 17, Assessment
13:19 Biochemistry Abbas Basement
2024 Biochemistry
Thursday, Formative Prof. Dr. Nabila
12:30- Lecture IT LAB
April 18, Assessment Kaukab/Dr.Sab
13:19 Anatomy Basement
2024 Embryology a
Monday,
12:30- Low Stake Lecture IT LAB
April 22, Dr.Saba
13:19 Assessment Anatomy Anatomy Basement
2024
Wednesday,
08:00- Integrated OSPE
April 24,
08:49 Observed
2024
Wednesday, 08:50- Integrated OSPE IT LAB
FOUNDATION MODULE 38
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

April 24,
09:39 Unobserved Basement
2024

FOUNDATION MODULE 39
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

FOUNDATION MODULE 40
FOUNDATION MODULE 2024 INTEGRATED CURRICULUM

FOUNDATION MODULE 41

You might also like